RecruitingPhase 2NCT07433426
5
studies recruiting now
as of 7 Sept 2026
65
studies registered in total
as of 7 Sept 2026
5
countries with a recruiting site
as of 7 Sept 2026
25 Feb 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 1NCT07205926
First in Human Dose Escalation Study Evaluating the Safety and Immunogenicity of IVT's Shigella-04 Vaccine in Healthy Young Adults
RecruitingPhase 2NCT07049159
Safety, and Efficacy Study of ShigETEC, a Live, Attenuated, Oral Combination Vaccine to Prevent Shigella and ETEC Disease Delivered to Healthy Adults Ages 18 to 50 Years Old
RecruitingPhase 1NCT05959616
Shigella Sonnei 53G Human Infection Study in Kenyan Adults
RecruitingPhase 1NCT05961059
InvaplexAR-Detox and DmLT Adjuvant in the Netherlands and Zambia
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
Search all Shigellosis studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Shigellosis study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Shigellosis
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
2 approved treatments and 6 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: AndrographolideApproved: Neoandrographolide
Phase 2Sodium Chloride (Aqsia (balanced salt soln))
Phase 2Ceftriaxone
Phase 2Sodium Butyrate
Phase 2Azithromycin (Azasite)
Phase 2Tebipenem Pivoxil (Orapenem)
Phase 1Ciprofloxacin (Cetraxal)
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).